Jaya Haldar

[1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine]arginine-vasopressin and [1-(.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropionic acid)]arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin

Marian Kruszynski, Bernard Lammek, Maurice Manning et al. · Journal of Medicinal Chemistry · 1980 · 448 citations

Neuropeptides, Altmetric Attention Score, Pharmacotherapy +20

DESIGN AND SYNTHESIS OF POTENT<i>IN VIVO</i>ANTAGONISTS OF OXYTOCIN

Krzysztof Bańkowski, Maurice Manning, Jenny Seto et al. · International journal of peptide & protein research · 1980 · 113 citations

Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin

Maurice Manning, Marian Kruszynski, Krzysztof Bańkowski et al. · Journal of Medicinal Chemistry · 1989 · 106 citations

Synthesis and some pharmacological properties of [4-threonine,7-glycine]oxytocin, [1-(L-2-hydroxy-3-mercaptopropanoic acid),4-threonine,7-glycine]oxytocin (hydroxy[thr4, gly7]oxytocin), and [7-glycine]oxytocin, peptides with high oxytocic-antidiuretic selectivity

John Lowbridge, Maurice Manning, Jaya Haldar et al. · Journal of Medicinal Chemistry · 1977 · 99 citations

Design of potent antagonists of the vasopressor response to arginine-vasopressin

Krzysztof Bańkowski, Maurice Manning, Jaya Haldar et al. · Journal of Medicinal Chemistry · 1978 · 87 citations

Bioorganic Chemistry, Vasopressor Potency, Vasopressor Response +12